医学
环磷酰胺
脑炎
甲基强的松龙
免疫疗法
NMDA受体
抗NMDA受体脑炎
麻醉
抗体
内科学
儿科
化疗
免疫学
受体
癌症
病毒
作者
Tadahiro Mitani,Yoshimitsu Ohtsuka,Kei Yamamoto,Yoshihiro Watanabe,Megumi Tsuji,Kiyoko Samejima,Noriko Aida,Takeshi Sato,Takahito Wada,Hitoshi Osaka
出处
期刊:PubMed
日期:2013-01-01
卷期号:45 (1): 53-7
摘要
We report on an 8-year-old boy with non-paraneoplastic anti-NMDA receptor (NMDAR) encephalitis, who presented with psychotic symptoms and involuntary movement following an intractable seizure. His serum and CSF tested positive for anti-NMDAR antibodies. He received an initial immunotherapy consisting of methylprednisolone pulse therapy (mPSL) and intravenous immunoglobulin therapy (IVIg), without any clinical improvement. He had three cycles of monthly cyclophosphamide pulse therapy (500 mg/m2), and his clinical condition started to improve gradually two weeks after the first cycle, without any side effects. Six months after onset, he tested normal upon standard neurological examination. Cyclophosphamide therapy should be considered for children with anti-NMDAR encephalitis, as well as mPSL and IVIg.
科研通智能强力驱动
Strongly Powered by AbleSci AI